Claudine Bruck
Direktor/Vorstandsmitglied bei ANNOVIS BIO, INC.
Vermögen: 43 014 $ am 31.05.2024
Aktive Positionen von Claudine Bruck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANNOVIS BIO, INC. | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Independent Dir/Board Member | 01.01.2015 | - | |
Prolifagen LLC | Gründer | 01.06.2016 | - |
Vorsitzender | 01.06.2016 | - | |
Vorstandsvorsitzender | 01.06.2016 | 13.09.2022 | |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Claudine Bruck
Ehemalige bekannte Positionen von Claudine Bruck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 05.03.2018 | 14.09.2021 |
Independent Dir/Board Member | 05.03.2018 | 14.09.2021 | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.01.1985 | - |
University of Pennsylvania | Corporate Officer/Principal | - | - |
Tufts University School of Medicine | Corporate Officer/Principal | - | - |
Ausbildung von Claudine Bruck
Vrije Universiteit Brussel | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Belgien | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
ANNOVIS BIO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Health Technology |
Prolifagen LLC | |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Health Technology |
- Börse
- Insiders
- Claudine Bruck
- Erfahrung